nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—esophageal cancer	0.609	1	CbGaD
Telaprevir—CTSS—exocrine gland—esophageal cancer	0.0146	0.113	CbGeAlD
Telaprevir—CMA1—smooth muscle tissue—esophageal cancer	0.0109	0.0836	CbGeAlD
Telaprevir—CTSS—neck—esophageal cancer	0.00936	0.072	CbGeAlD
Telaprevir—CMA1—digestive system—esophageal cancer	0.00858	0.066	CbGeAlD
Telaprevir—CMA1—lung—esophageal cancer	0.00717	0.0551	CbGeAlD
Telaprevir—CTSK—bronchus—esophageal cancer	0.00716	0.0551	CbGeAlD
Telaprevir—CTSK—smooth muscle tissue—esophageal cancer	0.007	0.0539	CbGeAlD
Telaprevir—CTSK—trachea—esophageal cancer	0.00643	0.0494	CbGeAlD
Telaprevir—CTSS—bronchus—esophageal cancer	0.00627	0.0482	CbGeAlD
Telaprevir—CTSS—smooth muscle tissue—esophageal cancer	0.00614	0.0472	CbGeAlD
Telaprevir—CTSS—trachea—esophageal cancer	0.00563	0.0433	CbGeAlD
Telaprevir—CTSK—digestive system—esophageal cancer	0.00553	0.0425	CbGeAlD
Telaprevir—CMA1—lymph node—esophageal cancer	0.0049	0.0377	CbGeAlD
Telaprevir—CTSS—digestive system—esophageal cancer	0.00485	0.0373	CbGeAlD
Telaprevir—CTSK—lung—esophageal cancer	0.00462	0.0355	CbGeAlD
Telaprevir—Boceprevir—ABCB1—esophageal cancer	0.00424	1	CrCbGaD
Telaprevir—CTSS—lung—esophageal cancer	0.00405	0.0311	CbGeAlD
Telaprevir—CTSK—lymph node—esophageal cancer	0.00316	0.0243	CbGeAlD
Telaprevir—CTSS—lymph node—esophageal cancer	0.00277	0.0213	CbGeAlD
Telaprevir—Pruritus genital—Capecitabine—esophageal cancer	0.00271	0.0397	CcSEcCtD
Telaprevir—ORM1—lung—esophageal cancer	0.00242	0.0186	CbGeAlD
Telaprevir—Proctalgia—Capecitabine—esophageal cancer	0.00241	0.0354	CcSEcCtD
Telaprevir—Swelling face—Capecitabine—esophageal cancer	0.00238	0.0349	CcSEcCtD
Telaprevir—Retinal disorder—Methotrexate—esophageal cancer	0.00236	0.0346	CcSEcCtD
Telaprevir—Lymphopenia—Capecitabine—esophageal cancer	0.00221	0.0324	CcSEcCtD
Telaprevir—Haemorrhoids—Capecitabine—esophageal cancer	0.00192	0.0282	CcSEcCtD
Telaprevir—Infection—Carboplatin—esophageal cancer	0.00185	0.0272	CcSEcCtD
Telaprevir—Oral candidiasis—Capecitabine—esophageal cancer	0.00178	0.0261	CcSEcCtD
Telaprevir—Hypothyroidism—Capecitabine—esophageal cancer	0.00176	0.0259	CcSEcCtD
Telaprevir—Hyperuricaemia—Cisplatin—esophageal cancer	0.00165	0.0243	CcSEcCtD
Telaprevir—ORM1—lymph node—esophageal cancer	0.00165	0.0127	CbGeAlD
Telaprevir—Blood uric acid increased—Cisplatin—esophageal cancer	0.00156	0.0229	CcSEcCtD
Telaprevir—ALB—lymph node—esophageal cancer	0.00145	0.0111	CbGeAlD
Telaprevir—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00125	0.0184	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00124	0.0183	CcSEcCtD
Telaprevir—CYP3A4—digestive system—esophageal cancer	0.00121	0.00929	CbGeAlD
Telaprevir—Renal failure acute—Cisplatin—esophageal cancer	0.00121	0.0177	CcSEcCtD
Telaprevir—ABCB1—epithelium—esophageal cancer	0.00112	0.00864	CbGeAlD
Telaprevir—Candida infection—Capecitabine—esophageal cancer	0.00108	0.0158	CcSEcCtD
Telaprevir—Blood creatinine increased—Cisplatin—esophageal cancer	0.00104	0.0153	CcSEcCtD
Telaprevir—Hypokalaemia—Cisplatin—esophageal cancer	0.00101	0.0149	CcSEcCtD
Telaprevir—ABCB1—trachea—esophageal cancer	0.000994	0.00764	CbGeAlD
Telaprevir—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000926	0.0136	CcSEcCtD
Telaprevir—Hyperuricaemia—Methotrexate—esophageal cancer	0.000908	0.0133	CcSEcCtD
Telaprevir—Renal failure acute—Capecitabine—esophageal cancer	0.000889	0.0131	CcSEcCtD
Telaprevir—Blood uric acid increased—Methotrexate—esophageal cancer	0.000857	0.0126	CcSEcCtD
Telaprevir—ABCB1—digestive system—esophageal cancer	0.000855	0.00658	CbGeAlD
Telaprevir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000812	0.0119	CcSEcCtD
Telaprevir—Blood creatinine increased—Capecitabine—esophageal cancer	0.000769	0.0113	CcSEcCtD
Telaprevir—Urinary tract disorder—Cisplatin—esophageal cancer	0.000761	0.0112	CcSEcCtD
Telaprevir—Urethral disorder—Cisplatin—esophageal cancer	0.000755	0.0111	CcSEcCtD
Telaprevir—Hypokalaemia—Capecitabine—esophageal cancer	0.000747	0.011	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000739	0.0109	CcSEcCtD
Telaprevir—Eye disorder—Cisplatin—esophageal cancer	0.00072	0.0106	CcSEcCtD
Telaprevir—ABCB1—lung—esophageal cancer	0.000714	0.00549	CbGeAlD
Telaprevir—Malnutrition—Cisplatin—esophageal cancer	0.000671	0.00984	CcSEcCtD
Telaprevir—Renal failure acute—Methotrexate—esophageal cancer	0.000662	0.00972	CcSEcCtD
Telaprevir—Infestation NOS—Capecitabine—esophageal cancer	0.000633	0.00929	CcSEcCtD
Telaprevir—Infestation—Capecitabine—esophageal cancer	0.000633	0.00929	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000627	0.00921	CcSEcCtD
Telaprevir—Anaemia—Cisplatin—esophageal cancer	0.00062	0.0091	CcSEcCtD
Telaprevir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000598	0.00878	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000567	0.00832	CcSEcCtD
Telaprevir—Urinary tract disorder—Capecitabine—esophageal cancer	0.000561	0.00823	CcSEcCtD
Telaprevir—Oedema peripheral—Capecitabine—esophageal cancer	0.000559	0.00821	CcSEcCtD
Telaprevir—Urethral disorder—Capecitabine—esophageal cancer	0.000557	0.00817	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00055	0.00808	CcSEcCtD
Telaprevir—Infection—Cisplatin—esophageal cancer	0.000544	0.00798	CcSEcCtD
Telaprevir—Erythema multiforme—Capecitabine—esophageal cancer	0.000537	0.00788	CcSEcCtD
Telaprevir—Nervous system disorder—Cisplatin—esophageal cancer	0.000537	0.00788	CcSEcCtD
Telaprevir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000536	0.00787	CcSEcCtD
Telaprevir—Skin disorder—Cisplatin—esophageal cancer	0.000532	0.0078	CcSEcCtD
Telaprevir—Eye disorder—Capecitabine—esophageal cancer	0.000531	0.00779	CcSEcCtD
Telaprevir—Eosinophilia—Methotrexate—esophageal cancer	0.000523	0.00768	CcSEcCtD
Telaprevir—Malnutrition—Capecitabine—esophageal cancer	0.000494	0.00726	CcSEcCtD
Telaprevir—ABCB1—lymph node—esophageal cancer	0.000488	0.00376	CbGeAlD
Telaprevir—Dysgeusia—Capecitabine—esophageal cancer	0.000484	0.00711	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000473	0.00694	CcSEcCtD
Telaprevir—Infestation NOS—Methotrexate—esophageal cancer	0.000471	0.00691	CcSEcCtD
Telaprevir—Infestation—Methotrexate—esophageal cancer	0.000471	0.00691	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000467	0.00685	CcSEcCtD
Telaprevir—Anaemia—Capecitabine—esophageal cancer	0.000457	0.00671	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000445	0.00654	CcSEcCtD
Telaprevir—Syncope—Capecitabine—esophageal cancer	0.000443	0.00651	CcSEcCtD
Telaprevir—Loss of consciousness—Capecitabine—esophageal cancer	0.000435	0.00638	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000418	0.00614	CcSEcCtD
Telaprevir—Urinary tract disorder—Methotrexate—esophageal cancer	0.000418	0.00613	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—esophageal cancer	0.000414	0.00608	CcSEcCtD
Telaprevir—Infection—Capecitabine—esophageal cancer	0.000401	0.00588	CcSEcCtD
Telaprevir—Erythema multiforme—Methotrexate—esophageal cancer	0.0004	0.00587	CcSEcCtD
Telaprevir—Shock—Capecitabine—esophageal cancer	0.000397	0.00583	CcSEcCtD
Telaprevir—Nervous system disorder—Capecitabine—esophageal cancer	0.000396	0.00581	CcSEcCtD
Telaprevir—Eye disorder—Methotrexate—esophageal cancer	0.000395	0.0058	CcSEcCtD
Telaprevir—Thrombocytopenia—Capecitabine—esophageal cancer	0.000395	0.0058	CcSEcCtD
Telaprevir—Asthenia—Cisplatin—esophageal cancer	0.000393	0.00576	CcSEcCtD
Telaprevir—Skin disorder—Capecitabine—esophageal cancer	0.000392	0.00575	CcSEcCtD
Telaprevir—Diarrhoea—Cisplatin—esophageal cancer	0.000375	0.0055	CcSEcCtD
Telaprevir—Malnutrition—Methotrexate—esophageal cancer	0.000368	0.0054	CcSEcCtD
Telaprevir—Dysgeusia—Methotrexate—esophageal cancer	0.00036	0.00529	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000348	0.00511	CcSEcCtD
Telaprevir—Vomiting—Cisplatin—esophageal cancer	0.000348	0.00511	CcSEcCtD
Telaprevir—Fatigue—Capecitabine—esophageal cancer	0.000348	0.00511	CcSEcCtD
Telaprevir—Rash—Cisplatin—esophageal cancer	0.000345	0.00507	CcSEcCtD
Telaprevir—Dermatitis—Cisplatin—esophageal cancer	0.000345	0.00506	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—esophageal cancer	0.00034	0.00499	CcSEcCtD
Telaprevir—Nausea—Cisplatin—esophageal cancer	0.000325	0.00477	CcSEcCtD
Telaprevir—Urticaria—Capecitabine—esophageal cancer	0.000321	0.0047	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000311	0.00457	CcSEcCtD
Telaprevir—Infection—Methotrexate—esophageal cancer	0.000298	0.00438	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—esophageal cancer	0.000295	0.00432	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—esophageal cancer	0.000294	0.00432	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—esophageal cancer	0.000292	0.00428	CcSEcCtD
Telaprevir—Asthenia—Capecitabine—esophageal cancer	0.00029	0.00425	CcSEcCtD
Telaprevir—Pruritus—Capecitabine—esophageal cancer	0.000285	0.00419	CcSEcCtD
Telaprevir—Diarrhoea—Capecitabine—esophageal cancer	0.000276	0.00405	CcSEcCtD
Telaprevir—Dizziness—Capecitabine—esophageal cancer	0.000267	0.00392	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000259	0.00381	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—esophageal cancer	0.000259	0.0038	CcSEcCtD
Telaprevir—Vomiting—Capecitabine—esophageal cancer	0.000257	0.00377	CcSEcCtD
Telaprevir—Rash—Capecitabine—esophageal cancer	0.000254	0.00373	CcSEcCtD
Telaprevir—Dermatitis—Capecitabine—esophageal cancer	0.000254	0.00373	CcSEcCtD
Telaprevir—Nausea—Capecitabine—esophageal cancer	0.00024	0.00352	CcSEcCtD
Telaprevir—Urticaria—Methotrexate—esophageal cancer	0.000239	0.0035	CcSEcCtD
Telaprevir—Asthenia—Methotrexate—esophageal cancer	0.000216	0.00316	CcSEcCtD
Telaprevir—Pruritus—Methotrexate—esophageal cancer	0.000213	0.00312	CcSEcCtD
Telaprevir—Diarrhoea—Methotrexate—esophageal cancer	0.000206	0.00302	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—ANXA1—esophageal cancer	0.000199	0.00105	CbGpPWpGaD
Telaprevir—Dizziness—Methotrexate—esophageal cancer	0.000199	0.00292	CcSEcCtD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000197	0.00104	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000194	0.00103	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—BCL2—esophageal cancer	0.000194	0.00103	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SST—esophageal cancer	0.000194	0.00103	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000193	0.00102	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000192	0.00102	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000192	0.00102	CbGpPWpGaD
Telaprevir—Vomiting—Methotrexate—esophageal cancer	0.000191	0.0028	CcSEcCtD
Telaprevir—Rash—Methotrexate—esophageal cancer	0.000189	0.00278	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—esophageal cancer	0.000189	0.00278	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—GHRL—esophageal cancer	0.000189	0.000999	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOTCH3—esophageal cancer	0.000189	0.000999	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB2—esophageal cancer	0.000188	0.000997	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CASP8—esophageal cancer	0.000186	0.000985	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FBXW7—esophageal cancer	0.000186	0.000983	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CREBBP—esophageal cancer	0.000185	0.000981	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB2—esophageal cancer	0.000181	0.000958	CbGpPWpGaD
Telaprevir—Nausea—Methotrexate—esophageal cancer	0.000178	0.00262	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000173	0.000916	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00017	0.000897	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOTCH2—esophageal cancer	0.000169	0.000896	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000169	0.000892	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ABL1—esophageal cancer	0.000167	0.000882	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ATP1B2—esophageal cancer	0.000166	0.000879	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CDKN1A—esophageal cancer	0.000161	0.000852	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000161	0.000851	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—BCL2—esophageal cancer	0.00016	0.000845	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000159	0.000843	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000157	0.00083	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000157	0.000829	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB2—esophageal cancer	0.000155	0.000821	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000155	0.00082	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDKN1A—esophageal cancer	0.000155	0.000818	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000155	0.000818	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TLR4—esophageal cancer	0.000153	0.000812	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EP300—esophageal cancer	0.000153	0.000811	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000153	0.000809	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000151	0.000797	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFBR2—esophageal cancer	0.00015	0.000795	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—DOCK2—esophageal cancer	0.00015	0.000795	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB2—esophageal cancer	0.000149	0.000789	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000146	0.000771	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000144	0.000761	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000144	0.000761	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SMAD4—esophageal cancer	0.000142	0.000753	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000142	0.00075	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000136	0.000721	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000135	0.000714	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000134	0.000709	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CDKN1A—esophageal cancer	0.000133	0.000702	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CASP8—esophageal cancer	0.000132	0.000697	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CREBBP—esophageal cancer	0.000131	0.000694	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—esophageal cancer	0.000131	0.000691	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.00013	0.00069	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00013	0.000688	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PFN1—esophageal cancer	0.00013	0.000686	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000129	0.00068	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDKN1A—esophageal cancer	0.000127	0.000674	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TLR4—esophageal cancer	0.000126	0.000669	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EP300—esophageal cancer	0.000126	0.000668	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000126	0.000667	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—esophageal cancer	0.000125	0.000664	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000125	0.00066	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000125	0.00066	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000119	0.000632	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000119	0.000629	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.000118	0.000624	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HIF1A—esophageal cancer	0.000116	0.000616	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000114	0.000605	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000114	0.000603	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PIK3CA—esophageal cancer	0.000113	0.0006	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000113	0.000598	CbGpPWpGaD
Telaprevir—CTSK—Immune System—BCL2—esophageal cancer	0.000113	0.000598	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000112	0.000591	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KDR—esophageal cancer	0.000111	0.000589	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000111	0.000586	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—esophageal cancer	0.00011	0.000581	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000109	0.000578	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000109	0.000578	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PIK3CA—esophageal cancer	0.000109	0.000576	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000109	0.000575	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CASP8—esophageal cancer	0.000108	0.000574	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CREBBP—esophageal cancer	0.000108	0.000571	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—esophageal cancer	0.000108	0.000569	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000106	0.00056	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CFL1—esophageal cancer	0.000105	0.000556	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOTCH1—esophageal cancer	0.000105	0.000555	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000105	0.000554	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—esophageal cancer	0.000103	0.000547	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GNG7—esophageal cancer	9.91e-05	0.000524	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—esophageal cancer	9.63e-05	0.000509	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CREBBP—esophageal cancer	9.51e-05	0.000503	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.48e-05	0.000502	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.45e-05	0.0005	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1A—esophageal cancer	9.38e-05	0.000496	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CA—esophageal cancer	9.34e-05	0.000494	CbGpPWpGaD
Telaprevir—CTSS—Immune System—BCL2—esophageal cancer	9.31e-05	0.000492	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—esophageal cancer	9.04e-05	0.000478	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	9.01e-05	0.000476	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CA—esophageal cancer	8.97e-05	0.000474	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EP300—esophageal cancer	8.93e-05	0.000472	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	8.88e-05	0.00047	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.58e-05	0.000454	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOS3—esophageal cancer	8.51e-05	0.00045	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	8.47e-05	0.000448	CbGpPWpGaD
Telaprevir—ALB—Metabolism—BLVRB—esophageal cancer	8.43e-05	0.000446	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC52A3—esophageal cancer	8.43e-05	0.000446	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	8.35e-05	0.000442	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.28e-05	0.000438	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HSPA5—esophageal cancer	8.08e-05	0.000427	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—esophageal cancer	7.96e-05	0.000421	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1A—esophageal cancer	7.73e-05	0.000409	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—esophageal cancer	7.61e-05	0.000403	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.53e-05	0.000399	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.51e-05	0.000398	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	7.43e-05	0.000393	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	7.4e-05	0.000391	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC52A3—esophageal cancer	7.38e-05	0.000391	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—BLVRB—esophageal cancer	7.38e-05	0.000391	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EP300—esophageal cancer	7.35e-05	0.000389	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA1—esophageal cancer	7.17e-05	0.000379	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC10A2—esophageal cancer	7.17e-05	0.000379	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—esophageal cancer	7.04e-05	0.000372	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1A—esophageal cancer	6.81e-05	0.00036	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—esophageal cancer	6.6e-05	0.000349	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA2—esophageal cancer	6.55e-05	0.000347	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EP300—esophageal cancer	6.48e-05	0.000343	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.41e-05	0.000339	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.38e-05	0.000337	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA1—esophageal cancer	6.28e-05	0.000332	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC10A2—esophageal cancer	6.28e-05	0.000332	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—esophageal cancer	6.27e-05	0.000332	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.2e-05	0.000328	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADH7—esophageal cancer	6.09e-05	0.000322	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLCE1—esophageal cancer	6.09e-05	0.000322	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.06e-05	0.00032	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.02e-05	0.000319	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ABL1—esophageal cancer	5.98e-05	0.000317	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA2—esophageal cancer	5.74e-05	0.000304	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—esophageal cancer	5.64e-05	0.000299	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—esophageal cancer	5.52e-05	0.000292	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.47e-05	0.00029	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—esophageal cancer	5.44e-05	0.000288	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADH1B—esophageal cancer	5.34e-05	0.000283	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADH7—esophageal cancer	5.34e-05	0.000282	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLCE1—esophageal cancer	5.34e-05	0.000282	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.29e-05	0.00028	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.23e-05	0.000276	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMP—esophageal cancer	5.11e-05	0.00027	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.04e-05	0.000267	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.02e-05	0.000265	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP26A1—esophageal cancer	4.97e-05	0.000263	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALOX15—esophageal cancer	4.84e-05	0.000256	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—esophageal cancer	4.79e-05	0.000253	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADH1B—esophageal cancer	4.68e-05	0.000248	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—esophageal cancer	4.63e-05	0.000245	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTO1—esophageal cancer	4.62e-05	0.000244	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TPI1—esophageal cancer	4.62e-05	0.000244	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.58e-05	0.000242	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.55e-05	0.000241	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.55e-05	0.000241	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMP—esophageal cancer	4.47e-05	0.000237	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALDOB—esophageal cancer	4.43e-05	0.000234	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.39e-05	0.000232	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.35e-05	0.00023	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—esophageal cancer	4.31e-05	0.000228	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.29e-05	0.000227	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GAPDH—esophageal cancer	4.26e-05	0.000225	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALOX15—esophageal cancer	4.24e-05	0.000224	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CRABP1—esophageal cancer	4.22e-05	0.000223	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TPI1—esophageal cancer	4.05e-05	0.000214	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTO1—esophageal cancer	4.05e-05	0.000214	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNG7—esophageal cancer	4.02e-05	0.000213	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALDOB—esophageal cancer	3.88e-05	0.000205	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CREBBP—esophageal cancer	3.87e-05	0.000205	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.87e-05	0.000205	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA1—esophageal cancer	3.87e-05	0.000205	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	3.79e-05	0.0002	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALDH2—esophageal cancer	3.76e-05	0.000199	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GAPDH—esophageal cancer	3.73e-05	0.000198	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.73e-05	0.000197	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CRABP1—esophageal cancer	3.7e-05	0.000196	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.61e-05	0.000191	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—esophageal cancer	3.58e-05	0.000189	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2A6—esophageal cancer	3.54e-05	0.000187	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA2—esophageal cancer	3.54e-05	0.000187	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.53e-05	0.000187	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNG7—esophageal cancer	3.52e-05	0.000186	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS3—esophageal cancer	3.47e-05	0.000183	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO1—esophageal cancer	3.36e-05	0.000178	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS1—esophageal cancer	3.36e-05	0.000178	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.35e-05	0.000177	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PSME1—esophageal cancer	3.31e-05	0.000175	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PSME2—esophageal cancer	3.31e-05	0.000175	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALDH2—esophageal cancer	3.3e-05	0.000174	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADH7—esophageal cancer	3.29e-05	0.000174	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.29e-05	0.000174	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—esophageal cancer	3.14e-05	0.000166	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.1e-05	0.000164	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO1—esophageal cancer	2.94e-05	0.000156	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS1—esophageal cancer	2.94e-05	0.000156	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.94e-05	0.000155	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PSME2—esophageal cancer	2.9e-05	0.000153	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PSME1—esophageal cancer	2.9e-05	0.000153	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.89e-05	0.000153	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.88e-05	0.000153	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1B1—esophageal cancer	2.85e-05	0.000151	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMP—esophageal cancer	2.76e-05	0.000146	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP19A1—esophageal cancer	2.68e-05	0.000142	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.68e-05	0.000142	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—esophageal cancer	2.64e-05	0.00014	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.61e-05	0.000138	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.5e-05	0.000132	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TPI1—esophageal cancer	2.49e-05	0.000132	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.49e-05	0.000132	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HMOX1—esophageal cancer	2.45e-05	0.000129	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.4e-05	0.000127	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.39e-05	0.000126	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.35e-05	0.000124	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—esophageal cancer	2.35e-05	0.000124	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.3e-05	0.000122	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.28e-05	0.000121	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNG7—esophageal cancer	2.17e-05	0.000115	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HMOX1—esophageal cancer	2.14e-05	0.000113	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.03e-05	0.000108	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—esophageal cancer	1.95e-05	0.000103	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.93e-05	0.000102	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.91e-05	0.000101	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—esophageal cancer	1.89e-05	9.99e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.81e-05	9.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO1—esophageal cancer	1.81e-05	9.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PSME2—esophageal cancer	1.78e-05	9.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PSME1—esophageal cancer	1.78e-05	9.44e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.78e-05	9.4e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CREBBP—esophageal cancer	1.57e-05	8.31e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.54e-05	8.15e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.45e-05	7.66e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NOS3—esophageal cancer	1.41e-05	7.44e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CREBBP—esophageal cancer	1.38e-05	7.28e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.32e-05	6.99e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—esophageal cancer	1.29e-05	6.8e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.27e-05	6.71e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NOS3—esophageal cancer	1.23e-05	6.52e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—esophageal cancer	1.13e-05	5.96e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—esophageal cancer	1.07e-05	5.66e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—esophageal cancer	9.37e-06	4.96e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.48e-06	4.48e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—esophageal cancer	7.91e-06	4.19e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NOS3—esophageal cancer	7.59e-06	4.01e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.94e-06	3.67e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.93e-06	3.67e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—esophageal cancer	5.77e-06	3.05e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.27e-06	2.26e-05	CbGpPWpGaD
